This meta-analysis of 21 200 patients found that finerenone can improve cardiovascular outcomes in patients with diabetes, chronic kidney disease, or heart failure.
This cross-sectional study evaluates how cardiovascular hospitalization rates compare in the US and Denmark, including differences by income level.
Vascular access is a commonly performed procedure to facilitate patient care. This document provides expert consensus from diverse specialists on best practices and techniques for…
Diuretic therapy is not associated with improved outcomes in heart failure and may cause significant side effects. Counteracting the core pathophysiological mechanisms of heart failure
DALLAS, Feb. 6, 2025 — To raise awareness that cardiovascular disease is the No. 1 killer of women, thousands of people and landmarks across the…
Background Relapsing–remitting (RR) and primary progressive (PP) multiple sclerosis (MS) have distinct clinical courses, but underlying pathophysiological differences remain unclear. We compared pat…
Background Blood-based biomarkers may offer a non-invasive approach to diagnose cerebral amyloid angiopathy (CAA), especially in early-stage. We evaluated the ability of plasma phosphorylated tau-21…
This meta-analysis of 21 200 patients found that finerenone can improve cardiovascular outcomes in patients with diabetes, chronic kidney disease, or heart failure.
Study evaluates the prognostic benefit of intravascular imaging-guided PCI in complex coronary lesions based on the number of complex features.
The manner in which clinical trial investigators present their findings to healthcare providers and the public can have a substantial influence on their impact. For…
